- Home
- SKYE vs AMPX Comparison
SKYE vs AMPX Comparison
Compare SKYE & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- AMPX
- Stock Information
- Founded
- SKYE 2012
- AMPX 2008
- Country
- SKYE United States
- AMPX United States
- Employees
- SKYE N/A
- AMPX N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- AMPX Industrial Machinery/Components
- Sector
- SKYE Health Care
- AMPX Miscellaneous
- Exchange
- SKYE Nasdaq
- AMPX Nasdaq
- Market Cap
- SKYE 115.9M
- AMPX 514.7M
- IPO Year
- SKYE N/A
- AMPX N/A
- Fundamental
- Price
- SKYE $3.98
- AMPX $6.45
- Analyst Decision
- SKYE Buy
- AMPX Strong Buy
- Analyst Count
- SKYE 6
- AMPX 7
- Target Price
- SKYE $16.60
- AMPX $9.29
- AVG Volume (30 Days)
- SKYE 2.2M
- AMPX 8.2M
- Earning Date
- SKYE 08-08-2025
- AMPX 08-07-2025
- Dividend Yield
- SKYE N/A
- AMPX N/A
- EPS Growth
- SKYE N/A
- AMPX N/A
- EPS
- SKYE N/A
- AMPX N/A
- Revenue
- SKYE N/A
- AMPX $33,115,000.00
- Revenue This Year
- SKYE N/A
- AMPX $167.22
- Revenue Next Year
- SKYE N/A
- AMPX $208.02
- P/E Ratio
- SKYE N/A
- AMPX N/A
- Revenue Growth
- SKYE N/A
- AMPX 209.20
- 52 Week Low
- SKYE $1.14
- AMPX $0.61
- 52 Week High
- SKYE $7.47
- AMPX $6.96
- Technical
- Relative Strength Index (RSI)
- SKYE 60.88
- AMPX 80.93
- Support Level
- SKYE $3.65
- AMPX $3.80
- Resistance Level
- SKYE $4.75
- AMPX $6.96
- Average True Range (ATR)
- SKYE 0.71
- AMPX 0.47
- MACD
- SKYE 0.00
- AMPX 0.23
- Stochastic Oscillator
- SKYE 48.55
- AMPX 86.40
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.